GLP-1R works through the combination of the endogenous ligand Glucagon-like peptide-1 (GLP-1) or exogenous agonists, which activate multiple intracellular signaling pathways that enhance insulin secretion, inhibit glucagon secretion, protect -cells from apoptosis, delay gastric emptying and increase satiety
Since insulin therapy often indicates more advanced disease progression, greater severity, or additional comorbidities, which may lead to a higher risk of intestinal obstruction, and there was no statistically significant difference in intestinal obstruction risk between GLP-1RAs and other anti-diabetic medications (e.g., SGLT2 inhibitors, metformin, sulfonylureas, thiazolidinediones, DPP-4 inhibitors), the observed reduction relative to insulin does not necessarily suggest a protective effect of GLP-1RAs against intestinal obstruction
Renal medullary blood flow is decreased in SS rats within a few days after the start of a high-salt diet 59,60
So when you hear someone saying, you can't blame your hormones for this, [00:48:11] it's all about lifestyle changes or it's all about this or that, your initial answer was nothing in biology is black and white
In cystic fibrosis, NAC provides anti-inflammatory, antioxidant, and antibiofilm effects, with emerging evidence supporting its role in non-CF bronchiectasis
